The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

20 Mar 2013 07:00

RNS Number : 3786A
Standard Life Euro Pri Eqty Tst PLC
20 March 2013
 

 

 

 

Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter from 1 October to 31 December 2012

 

·; NAV increased 1.3% to 230.5p for the quarter ended 31 December 2012

·; Net realised gains/income and unrealised gains on a constant exchange rate basis rose 0.3%, while there was an unrealised foreign exchange gain of 1.4%

·; 100% by value of the portfolio was valued by the respective underlying managers at 31 December 2012

·; Outstanding commitments were £154.7 million at 31 December 2012

·; Net cash balance was £3.1 million at 31 December 2012

 

For the quarter ended 31 December 2012 the Company's net asset value per ordinary share ("NAV") increased by 1.3% to 230.5p (diluted NAV - 227.7p), from 227.6p at 30 September 2012 (diluted NAV - 224.9p). At 31 December 2012 the Company's net assets were £374.0 million (30 September 2012 - £369.7 million).

 

The quarter ended 31 December 2012 saw an increase in new investment and realisation activity in the European private equity market, notably for transactions with an enterprise value over €1 billion. The value of all new private equity transactions in the European private equity market announced during the quarter was €24.6 billion (quarter ended 30 September 2012 - €13.5 billion), of which €22.8 billion comprised buy-out transactions (quarter ended 30 September 2012 - €12.3 billion).

 

Distributions received by the Company during the quarter ended 31 December 2012 were £17.3 million (quarter ended 30 September 2012 - £32.0 million) and the Company funded £15.4 million of draw downs (quarter ended 30 September 2012 - £15.9 million). The distributions received by the Company generated net realised gains and income of £9.3 million. In addition, the Company incurred a book loss of £6.5 million on the commencement of the liquidation process for two older funds, Alchemy Investment Plan and the Candover 1997 Fund, where all of the underlying investments have been realised. Importantly, the book loss had previously been provided for in the Company's valuation of the respective fund interests.

 

The closing value of the Company's portfolio of 39 private equity fund interests was £370.4 million at 31 December 2012 (30 September 2012 - 37 fund interests and £365.9 million). Total net unrealised gains on the portfolio for the quarter were £3.6 million, of which £1.6 million were net unrealised losses on a constant exchange rate basis and £5.2 million were net unrealised foreign exchange gains. During the quarter ended 31 December 2012 sterling depreciated by 1.8% against the euro and appreciated by 0.7% against the US dollar.

 

In line with the Company's investment strategy, a new commitment of €20.0 million was made to Advent Global Private Equity VII in November 2012 and one of €30.0 million was made to IK VII in December 2012. The Company has invested in prior funds of each of the respective managers. At 31 December 2012 the Company had aggregate outstanding commitments of £154.7 million (30 September 2012 - £129.0 million).

 

At 31 December 2012 the Company had a net cash balance of £3.1 million (30 September 2012 - net cash balance of £3.5 million).

 

On 31 December 2012 the Company announced that it had entered into a new £80 million revolving credit facility, led by The Royal Bank of Scotland plc, replacing the Company's existing debt facility. The new debt facility expires on 31 December 2016.

 

 

2. Events and transactions since 1 January 2013

 

During January 2013 the Company completed the purchase of an original commitment of €7.0 million to Charterhouse Capital Partners IX, a fund the Company was not able to commit to when it was raised in 2009. The fund interest was acquired at a 5% discount to the 30 June 2012 valuation of the fund, adjusted for subsequent cashflows. The purchase price for the interest was £2.8 million and the Company assumed £2.8 million of outstanding commitments.

 

As part of a portfolio rebalancing exercise, and given the significant exposure to the fund and its underlying investments, the Company also completed the sale of 50% of its original commitment to Charterhouse VIII in February 2013. The fund interest was sold at an 11% discount to the 30 September 2012 valuation of the fund, adjusted for subsequent cashflows. The sale price for the interest was £16.3 million and the Company was released from £3.5 million of outstanding commitments. Adjusting the NAV at 31 December 2012 disclosed in section 1 above for the disposal of the interest in Charterhouse VIII would have reduced the NAV by 1.2p, or 0.5%.

 

Excluding the above secondary transactions, during the period from 1 January to 18 March 2013 the Company received £4.5 million of distributions and funded £2.3 million of draw downs. At 18 March 2013 the Company had a net cash balance of £16.0 million.

 

Finally, the Company made a new commitment of $35 million to TowerBrook Investors IV in February 2013. Again the Company has invested in prior funds of the manager. Accordingly, at 18 March 2013 the Company had aggregate outstanding commitments of £182.9 million.

 

It is anticipated that the Company will release its interim announcement for the six months ending 31 March 2013 on or around 30 May 2013.

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1148 - 1165 of the Corporation Taxes Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEKLFFXXFEBBD
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.